Journal Article

A comparison between 1,25-dihydroxy-22-oxavitamin D<sub>3</sub> and 1,25-dihydroxyvitamin D<sub>3</sub> regarding suppression of parathyroid hormone secretion and calcaemic action

Michinori Hirata, Koichi Endo, Kyoko Katsumata, Fumihiko Ichikawa, Noboru Kubodera and Masafumi Fukagawa

in Nephrology Dialysis Transplantation

Published on behalf of European Renal Association - European Dialysis and Transplant Assoc

Volume 17, issue suppl_10, pages 41-45
Published in print October 2002 | ISSN: 0931-0509
Published online October 2002 | e-ISSN: 1460-2385 | DOI:
A comparison between 1,25-dihydroxy-22-oxavitamin D3 and 1,25-dihydroxyvitamin D3 regarding suppression of parathyroid hormone secretion and calcaemic action

Show Summary Details


Background. Since Slatopolsky et al. (J Clin Invest 1984; 74: 2136–2143) reported the effect of active vitamin D, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), on secondary hyperparathyroidism (2HPT) which accompanies chronic renal failure, there have been several studies of the therapeutic effects of 1,25(OH)2D3 in this disease. Although parathyroid hormone (PTH) is suppressed by treatment with 1,25(OH)2D3, long-term treatment with 1,25(OH)2D3 tends to induce hypercalcaemia. Therefore, an analogue of 1,25(OH)2D3, 1,25-dihydroxy-22-oxavitamin D3 (22-oxacalcitriol, OCT) with less calcaemic activity, was developed for the treatment of 2HPT.

Methods. In order to clarify the differences between the effects of 1,25(OH)2D3 and OCT on 2HPT associated with chronic renal failure, these compounds were administered by intermittent i.v. injection for 2 weeks in rats with mild to moderate uraemia.

Results. 1,25(OH)2D3 markedly suppressed PTH levels, but increased serum calcium (Ca). OCT also markedly suppressed PTH levels, but induced only a slight increase in serum Ca. 1,25(OH)2D3 caused a dose-dependent decrease in body weight, whereas OCT had no effect on body weight in uraemic rats. Based on those doses of OCT and 1,25(OH)2D3, which resulted in a 60% suppression of PTH, and induced hypercalcaemia, we consider the relative ratios for efficacy and Ca-elevating activity between OCT and 1,25(OH)2D3 to be 1: 8 and 1: 48, respectively.

Conclusions. OCT suppressed PTH levels with a slight increase in serum Ca without changing the body weight in uraemic rats. This observation suggests that OCT might be a useful vitamin D analogue for 2HPT management in long-term clinical treatment.

Keywords: calcaemic action; 22-oxacalcitriol; OCT; 1,25(OH)2D3; parathyroid hormone; secondary hyperparathyroidism

Journal Article.  0 words. 

Subjects: Nephrology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.